3rd Annual Workshop on Genomics: Genomics and Translational Medicine in Myeloma

July 11 - 12, 2025 - Lisbon, Portugal

The IMS Workshop on Genomics was developed in response to the IMS-FDA joint workshop to further consider essential needs in myeloma. The initial invitation-only meeting in 2023 provided an opportunity for myeloma experts from around the world to develop a consensus to define ‘high-risk multiple myeloma’. Building upon this success, the Third IMS Genomics Meeting will be a public meeting led by global myeloma KOL.

More details will be available soon.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

See All of the Member Benefits

Become a Member Today

Stay updated on our Events

Become a Member

Name*
First Last
Title (MD, PhD, etc)
Birth Date
MM slash DD slash YYYY
Email Address*
Enter Email Confirm Email
Admin Assistant Email Address
Password*
Enter Password Confirm Password
Medical Center
Country*
Consent
Sign-Up for Our Newsletter?

3rd Annual Workshop on Genomics: Genomics and Translational Medicine in Myeloma

Why Become a Member

Stay updated on our Events

Already a Member

Reset Password

Become a Member